CDKN2A and melanoma: This variant is a North American founder mutation believed to pre-date colonization.<h4>Conclusions</h4>This case reminds clinicians to consider the possibility of a germline <i>CDKN2A</i> mutation in families with a high prevalence of PDAC, even in the absence of moles or melanoma.